Senzagen Ab Stock Current Valuation
| SENZA Stock | SEK 4.98 0.02 0.40% |
Valuation analysis of SenzaGen AB helps investors to measure SenzaGen's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
Please note that SenzaGen's price fluctuation is slightly risky at this time. Calculation of the real value of SenzaGen AB is based on 3 months time horizon. Increasing SenzaGen's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the SenzaGen stock is determined by what a typical buyer is willing to pay for full or partial control of SenzaGen AB. Since SenzaGen is currently traded on the exchange, buyers and sellers on that exchange determine the market value of SenzaGen Stock. However, SenzaGen's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 4.98 | Real 4.73 | Hype 4.98 | Naive 4.8 |
The intrinsic value of SenzaGen's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence SenzaGen's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of SenzaGen AB helps investors to forecast how SenzaGen stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of SenzaGen more accurately as focusing exclusively on SenzaGen's fundamentals will not take into account other important factors: SenzaGen AB Company Current Valuation Analysis
SenzaGen's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current SenzaGen Current Valuation | 255.67 M |
Most of SenzaGen's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, SenzaGen AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, SenzaGen AB has a Current Valuation of 255.67 M. This is 98.22% lower than that of the Healthcare sector and 94.5% lower than that of the Biotechnology industry. The current valuation for all Sweden stocks is 98.46% higher than that of the company.
SenzaGen Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses SenzaGen's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of SenzaGen could also be used in its relative valuation, which is a method of valuing SenzaGen by comparing valuation metrics of similar companies.SenzaGen is currently under evaluation in current valuation category among its peers.
SenzaGen Fundamentals
| Return On Equity | -0.32 | |||
| Return On Asset | -0.17 | |||
| Profit Margin | (1.02) % | |||
| Operating Margin | (0.95) % | |||
| Current Valuation | 255.67 M | |||
| Shares Outstanding | 24.19 M | |||
| Shares Owned By Insiders | 37.29 % | |||
| Shares Owned By Institutions | 8.24 % | |||
| Price To Book | 3.31 X | |||
| Price To Sales | 10.69 X | |||
| Revenue | 15.42 M | |||
| Gross Profit | 9.45 M | |||
| EBITDA | (27.08 M) | |||
| Net Income | (31.35 M) | |||
| Cash And Equivalents | 69.16 M | |||
| Cash Per Share | 3.63 X | |||
| Total Debt | 714 K | |||
| Current Ratio | 13.07 X | |||
| Book Value Per Share | 4.08 X | |||
| Cash Flow From Operations | (20.98 M) | |||
| Earnings Per Share | (1.35) X | |||
| Target Price | 16.0 | |||
| Number Of Employees | 29 | |||
| Beta | 0.47 | |||
| Market Capitalization | 308.55 M | |||
| Total Asset | 133.81 M | |||
| Net Asset | 133.81 M |
About SenzaGen Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze SenzaGen AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of SenzaGen using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of SenzaGen AB based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for SenzaGen Stock Analysis
When running SenzaGen's price analysis, check to measure SenzaGen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SenzaGen is operating at the current time. Most of SenzaGen's value examination focuses on studying past and present price action to predict the probability of SenzaGen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SenzaGen's price. Additionally, you may evaluate how the addition of SenzaGen to your portfolios can decrease your overall portfolio volatility.